Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Mair, A. Berghoff (2021)
ASCO 2021: Highlights in central nervous system tumorsmemo - Magazine of European Medical Oncology, 14
A. Ilhan-Mutlu (2021)
ASCO 2021–Gastroesophageal tumor highlightsmemo - Magazine of European Medical Oncology, 14
Anne Hertenstein, M. Plattén, W. Wick (2016)
Highlights in Central Nervous System Tumors.JAMA oncology, 2 12
T. Fuereder (2021)
ASCO 2021 highlights head and neck cancer: nasopharyngeal carcinomamemo - Magazine of European Medical Oncology, 14
K. Mayrhofer, D. Niedersüss-Beke (2021)
Best of ASCO 2021—bladder cancermemo - Magazine of European Medical Oncology, 14
C. Singer (2021)
Best of ASCO 2021: new data from triple-negative breast cancermemo - Magazine of European Medical Oncology, 14
L. Weiss (2021)
ASCO 2021—an update on metastastic colorectal cancermemo - Magazine of European Medical Oncology, 14
J. Schöche, K. Strasser-Weippl (2021)
Ovarian cancer—ASCO annual meeting update 2021memo - Magazine of European Medical Oncology, 14
G. Absenger, A. Pircher (2021)
ASCO 2021—selection of personal highlights in early stage non-small cell lung cancermemo - Magazine of European Medical Oncology, 14
editorial memo (2021) 14:313–314 https://doi.org/10.1007/s12254-021-00768-4 Ewald Wöll Accepted: 29 September 2021 © Springer-Verlag GmbH Austria, part of Springer Nature 2021 In the current issue of the Magazine of European Med- Drs. Absenger and Pircher highlight their non-small ical Oncology (MEMO), we provide a series of articles cell lung cancer favorites. First data on adjuvant ate- summarizing the most relevant presentations deliv- zolizumab show promising results. In addition two ered at ASCO 2021 on central nervous system tumors, trials in resected EGFR-mutated patients elucidating upper gastrointestinal (GI)cancers, triple-negative the effect of neo/adjuvant treatment with gefitinib or breast cancer (TNBC), nasopharyngeal carcinoma, erlotinib are reported [5]. early stage non-small cell lung cancer, advanced ovar- Drs. Schöche and Strasser-Weippl present the ther- ian cancer, bladder cancer, and metastastic colorectal apeutic medical landscape in advanced ovarian can- cancer. cer and several interesting studies that might have Drs. Berghoff and Mair discuss recent advances in aclinical impact inthe future [6]. central nervous system tumors. The data presented Drs. Mayrhofer, K. and Niedersüß-Beke review show interesting aspects of molecular platform diag- the papers on bladder cancer. Three phase II trials nostics and promising results on targeted therapies address the incorporation of immunotherapy in in- [1].
memo - Magazine of European Medical Oncology – Springer Journals
Published: Dec 1, 2021
Keywords: oncology; medicine/public health, general
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.